Asia Pharmaceutical Industries

Belkins
ASIA Pharmaceutical Industries is one of the pioneering pharmaceutical companies in Syria and the Middle East. Within two decades, a dedicated and highly qualified team of scientists and healthcare professionals has developed a world-class company that has been awarded international quality certificates: cGMPs, ISO 9001, ISO 14001 as well as the OHSAS 18001.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BIG PHARMA RETURNING TO U.S. PRICE HIKES IN JANUARY AFTER PAUSE

Reuters: | February 19, 2020

news image

Novartis AG (NOVN.S) and Bayer AG (BAYGn.DE) are among nearly 30 drugmakers that have taken steps to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by a pharma industry under pressure from the Trump administration, according to documents seen by Reuters. Other drugmakers set to raise prices at the start of 2019 include Allergan Plc (AGN.N), GlaxoSmithKline Plc (GSK.L), Amgen Inc (AMGN.O), AstraZeneca Plc (AZN.L) and Biogen Inc (BIIB.O), the doc...

Read More

NEW JERSEY PHARMACEUTICAL COMPANY DONATES 400,000 TABLETS TO LOUISIANA FOR CLINICAL TRIALS IN COVID-19 TREATMENT

WBRZ- | March 30, 2020

news image

Louisiana Attorney General Jeff Landry, working with the assistance of State Senate Health and Welfare Chairman Fred Mills issued a statement Monday, announcing that Amneal Pharmaceuticals is donating 400,000 hydroxychloroquine sulfate tablets to the State of Louisiana to assist with the COVID-19 pandemic. "On behalf of Louisiana, I want to thank Amneal for this generous donation," said General Landry. "Amneal's donation is one step toward trying to find treatments and cures f...

Read More

PHARMACY MARKET

EMA STARTS ROLLING REVIEW OF CUREVAC’S COVID-19 VACCINE (CVNCOV)

CureVac, EMA | February 18, 2021

news image

The European Medicines Agency (EMA's) Committee for Human Medicinal Products (CHMP) has begun a moving audit of CureVac AG's COVID-19 antibodies, CVnCoV. The survey was started on the grounds that starter research facility contemplates and early clinical preliminary outcomes recommend the immunization triggers the creation of antibodies and insusceptible cells that target SARS-CoV-2, the infection that causes COVID‑19. The survey will successively audit info...

Read More

APHA: TRANSPARENCY, SAFETY AND AVAILABILITY MUST BE CORE PRINCIPLES FOR STRENGTHENING AMERICA'S DRUG SUPPLY CHAIN

APhA | August 11, 2020

news image

The reliability, quality and safety of our nation's drug supply chain are essential to the nation's security and health and well-being of the American public. Therefore, we welcome comprehensive federal efforts to improve the state of our drug supply chain, particularly at a time when our health care system is under extraordinary stress. The President's Executive Order last week, "Ensuring Essential Medicines, Medical Countermeasures and Critical Inputs Are Made in the United St...

Read More

Reuters: | February 19, 2020

news image

BIG PHARMA RETURNING TO U.S. PRICE HIKES IN JANUARY AFTER PAUSE

Novartis AG (NOVN.S) and Bayer AG (BAYGn.DE) are among nearly 30 drugmakers that have taken steps to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by a pharma industry under pressure from the Trump administration, according to documents seen by Reuters. Other drugmakers set to raise prices at the start of 2019 include Allergan Plc (AGN.N), GlaxoSmithKline Plc (GSK.L), Amgen Inc (AMGN.O), AstraZeneca Plc (AZN.L) and Biogen Inc (BIIB.O), the doc...

Read More

WBRZ- | March 30, 2020

news image

NEW JERSEY PHARMACEUTICAL COMPANY DONATES 400,000 TABLETS TO LOUISIANA FOR CLINICAL TRIALS IN COVID-19 TREATMENT

Louisiana Attorney General Jeff Landry, working with the assistance of State Senate Health and Welfare Chairman Fred Mills issued a statement Monday, announcing that Amneal Pharmaceuticals is donating 400,000 hydroxychloroquine sulfate tablets to the State of Louisiana to assist with the COVID-19 pandemic. "On behalf of Louisiana, I want to thank Amneal for this generous donation," said General Landry. "Amneal's donation is one step toward trying to find treatments and cures f...

Read More

PHARMACY MARKET

CureVac, EMA | February 18, 2021

news image

EMA STARTS ROLLING REVIEW OF CUREVAC’S COVID-19 VACCINE (CVNCOV)

The European Medicines Agency (EMA's) Committee for Human Medicinal Products (CHMP) has begun a moving audit of CureVac AG's COVID-19 antibodies, CVnCoV. The survey was started on the grounds that starter research facility contemplates and early clinical preliminary outcomes recommend the immunization triggers the creation of antibodies and insusceptible cells that target SARS-CoV-2, the infection that causes COVID‑19. The survey will successively audit info...

Read More

APhA | August 11, 2020

news image

APHA: TRANSPARENCY, SAFETY AND AVAILABILITY MUST BE CORE PRINCIPLES FOR STRENGTHENING AMERICA'S DRUG SUPPLY CHAIN

The reliability, quality and safety of our nation's drug supply chain are essential to the nation's security and health and well-being of the American public. Therefore, we welcome comprehensive federal efforts to improve the state of our drug supply chain, particularly at a time when our health care system is under extraordinary stress. The President's Executive Order last week, "Ensuring Essential Medicines, Medical Countermeasures and Critical Inputs Are Made in the United St...

Read More